Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Thakuria

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Investigative Dermatology|February 20, 2013
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responsesMitra Dowlatshahi, Victor Huang, Ahmed E Gehad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2022
Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinomaKevin X Liu, Michael G Milligan, Jonathan D Schoenfeld, et al.
Journal of the American Academy of Dermatology|February 19, 2026
Response to Gao and Chen, "Comments on Akaike et al.'s 'Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management'"Tomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Genome Medicine|March 20, 2020
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinomaGabriel J Starrett, Manisha Thakuria, Tianqi Chen, et al.
The Journal of Investigative Dermatology|February 2, 2016
ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma GrowthSonja Kleffel, Nayoung Lee, Cecilia Lezcano, et al.
Science Advances|January 19, 2024
Tumor cell-intrinsic PD-1 promotes Merkel cell carcinoma growth by activating downstream mTOR-mitochondrial ROS signalingChristina Martins, Erik Rasbach, Markus V Heppt, et al.
JAMA Dermatology|July 8, 2026
ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma RecurrenceManisha Thakuria, Tomoko Akaike, Ann W Silk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic ImplicationsTomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Journal of the American Academy of Dermatology|October 12, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient managementTomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Investigative Dermatology|February 20, 2013
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responsesMitra Dowlatshahi, Victor Huang, Ahmed E Gehad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2022
Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinomaKevin X Liu, Michael G Milligan, Jonathan D Schoenfeld, et al.
Journal of the American Academy of Dermatology|February 19, 2026
Response to Gao and Chen, "Comments on Akaike et al.'s 'Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management'"Tomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Genome Medicine|March 20, 2020
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinomaGabriel J Starrett, Manisha Thakuria, Tianqi Chen, et al.
The Journal of Investigative Dermatology|February 2, 2016
ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma GrowthSonja Kleffel, Nayoung Lee, Cecilia Lezcano, et al.
Science Advances|January 19, 2024
Tumor cell-intrinsic PD-1 promotes Merkel cell carcinoma growth by activating downstream mTOR-mitochondrial ROS signalingChristina Martins, Erik Rasbach, Markus V Heppt, et al.
JAMA Dermatology|July 8, 2026
ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma RecurrenceManisha Thakuria, Tomoko Akaike, Ann W Silk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic ImplicationsTomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Journal of the American Academy of Dermatology|October 12, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient managementTomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Pageof 5